Abstract
Medulloblastoma, the most common tumor of the central nervous system (CNS) in childhood, represents approximately 20% of all pediatric intracranial neoplasms. It is classified as grade IV tumor by the World Health Organization (WHO) and divided into five subtypes: classic, desmoplastic/nodular, with extensive nodularity, anaplastic and large cell. The current challenge in medulloblastoma …